HYPR Hyperfine, Inc.

NEUTRAL Impact: 4/10 EFFECT
Horizon weeks Filed May 22, 2026 Processed 24d 1h ago SEC 9999999995-26-001730
IPO/offering going effective
Latest settled — T+5d
HYPR ▲ +2.01% at T+5d
NEUTRAL call ✓ call won +2.01% · α vs SPY +0.36% · entry $1.49 → $1.52
Next anchor: T+20d in 8d
Last close $1.36 (close Jun 12) · -8.72% from $1.49 entry
Entry anchored
May 22, 2026
via day open
T+1d
+11.41%
call +11.41% · α +10.82%
$1.66
settled 20d ago
T+5d
+2.01%
call +2.01% · α +0.36%
$1.52
settled 14d ago
T+20d
call — · α —
in 8d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Hyperfine's S-3 shelf registration (File No. 333-295807) became effective on May 21, 2026, enabling the resale of 1,083,335 shares of Class A common stock by Horizon Technology Finance affiliates. These shares were issued as warrants in a $15.0M debt financing in March 2026, and the company will receive up to ~$1.3M only if the warrants are exercised for cash. The effectiveness is a routine procedural step tied to contractual registration rights, not a new capital raise, and follows strong Q1 2026 earnings (revenue up 83% YoY).

Actionable Insight

The effective shelf creates a modest overhang of up to ~1.1M shares (less than 1% of float), but the registration is for existing warrant shares, not a new offering. Monitor for any subsequent takedown notice or prospectus supplement that would signal actual selling. The strong Q1 results and extended cash runway reduce the likelihood of a distress-driven offering.

Key Facts

  • S-3 shelf registration (333-295807) became effective on May 21, 2026.
  • Registration covers 1,083,335 shares of Class A common stock for resale by Horizon Technology Finance affiliates.
  • Shares were issued as warrants in a $15.0M debt financing from March 2026.
  • Company receives up to ~$1.3M only if warrants are exercised for cash.
  • Q1 2026 revenue grew 83% YoY to $3.90M; net loss narrowed to $8.62M.
  • Cash runway extended into 2028 per prior S-3 filing context.

Financial Impact

Up to ~$1.3M in potential cash proceeds if warrants are exercised; no immediate dilution from the shelf itself.

dilutioncash

Risk Factors

  • Potential dilution if warrant holders exercise and sell into the market.
  • Shelf could be used for future offerings if the company's cash position deteriorates.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
89% bullish (9 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001730
Document: 9999999995-26-001730-index.html9999999995-26-001730
Document: 9999999995-26-001730.txt9999999995-26-001730
4 reports for HYPR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for HYPR — sortable, filterable
Type Now
May 22, 2026
24d ago
EFFECT
NEUTRAL ★ 4/10
$1.49 $1.52▲ +2.01%▲ +0.36%$1.36 (−8.72%)
May 12, 2026
4w ago
S-3
NEUTRAL ★ 4/10
$1.59 $1.41▼ −11.32%▼ −10.16%$1.36 (−14.47%)
Apr 8, 2026
9w ago
DEFA14A
NEUTRAL ★ 2/10
$1.21 $1.33▲ +9.92%▲ +6.73%$1.36 (+12.40%)
Mar 23, 2026
12w ago
Insider Cluster
BEARISH ★ 5/10
$1.21 $1.03▲ +14.88%▲ +11.31%$1.36 (−12.40%)
Showing 4 of 4

US Market Status

Market Closed — Opens in 1h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access